| Unique ID issued by UMIN | UMIN000056844 |
|---|---|
| Receipt number | R000064967 |
| Scientific Title | Goal of Dynamic Strategy by Aggressive Lipid Intervention in Acute Myocardial Infarction |
| Date of disclosure of the study information | 2025/02/02 |
| Last modified on | 2025/01/28 16:44:41 |
Goal of Dynamic Strategy by Aggressive Lipid Intervention in Acute Myocardial Infarction
GOODBYLIPID-AMI
Goal of Dynamic Strategy by Aggressive Lipid Intervention in Acute Myocardial Infarction
GOODBYLIPID-AMI
| Japan |
Acute Myocardial Infarction
| Medicine in general | Cardiology |
Others
NO
To evaluate the efficacy of lipid-lowering therapy for residual coronary plaque in patients undergoing percutaneous coronary intervention by cardiac catheter for acute myocardial infarction
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
Since this is an exploratory study to determine the efficacy of lipid-lowering therapy for residual coronary plaque in non-culprit lesions in patients undergoing PCI for AMI, the principal investigator or investigators will determine the endpoints and analysis methods after data collection.
Observational
| 18 | years-old | <= |
| 85 | years-old | >= |
Male and Female
Patients who meet all of the following eligibility criteria
(1) 18 years of age or older and less than 85 years of age
(2) Have one of the following residual lesions at the time of PCI for AMI
i) Coronary angiographic stenosis between 25% and 75%.
ii) Coronary angiographic stenosis of 75% to less than 90% and FFR >0.80 or Resting Index >0.89
(3) Fasting LDL-C level >55 mg/dL during hospitalization
(4) Written consent for participation in the study is obtained from the patient.
(1) eGFR<30 ml/min/1.73m2
(2) Current or historical use of PCSK9 inhibitors or sustained LDL-C-lowering siRNA agents
(3) Scheduled PCI or CABG for residual coronary artery lesions under study
(4) Complicated congenital heart disease
(5) Patients with a permanent pacemaker or internal defibrillation leads
(6) Patients after artificial heart valve replacement
(7) Patients with arrhythmia or tachycardia that interferes with CT data acquisition
(8) Patients with body mass index (BMI) >35
(9) Patients with contraindication to nitrates
(10) Patients with no prognosis for more than 1-year
(11) Patients who participated in clinical trials with other drugs
(11) Patients participating in clinical trials with other drugs
(12) Patients under conditions that may interfere with patient safety or protocol compliance
(13) Patients who are deemed unsuitable by the principal investigator or sub investigator
300
| 1st name | Tomoya |
| Middle name | |
| Last name | Ueda |
Nara Medical University
Department of Cardiovascular Medicine
634-8522
840 Shijo-cho, Kashihara, Nara, Japan
0744-22-3051
tom15@naramed-u.ac.jp
| 1st name | Kazutaka |
| Middle name | |
| Last name | Nogi |
Nara Medical University
Department of Cardiovascular Medicine
634-8522
840 Shijo-cho, Kashihara, Nara, Japan
0744-22-3051
nogi18kazu@dream.jp
Nara Medical University
Self-funding
Self funding
Nara Medical University Research Ethics Committee
840 Shijo-cho, Kashihara, Nara, Japan
0744-22-3051
ino_rinri@naramed-u.ac.jp
NO
奈良県立医科大学附属病院、奈良県総合医療センター、奈良県西和医療センター、市立奈良病院
| 2025 | Year | 02 | Month | 02 | Day |
Unpublished
Preinitiation
| 2024 | Year | 10 | Month | 08 | Day |
| 2025 | Year | 01 | Month | 22 | Day |
| 2025 | Year | 02 | Month | 02 | Day |
| 2032 | Year | 03 | Month | 31 | Day |
Evaluate the efficacy of lipid-lowering therapy for residual coronary plaque in patients undergoing percutaneous coronary intervention by cardiac catheter for acute myocardial infarction
| 2025 | Year | 01 | Month | 28 | Day |
| 2025 | Year | 01 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064967